140 related articles for article (PubMed ID: 34510261)
21. Periosteal microcirculatory reactions in a zoledronate-induced osteonecrosis model of the jaw in rats.
Janovszky Á; Szabó A; Varga R; Garab D; Boros M; Mester C; Beretka N; Zombori T; Wiesmann HP; Bernhardt R; Ocsovszki I; Balázs P; Piffkó J
Clin Oral Investig; 2015 Jul; 19(6):1279-88. PubMed ID: 25352470
[TBL] [Abstract][Full Text] [Related]
22. Maximum and mean standardized uptake values of medication-related osteonecrosis of the jaw with bone SPECT/CT: comparison of mandibular pathologies, control and temporomandibular joints.
Tezuka Y; Ogura I
Dentomaxillofac Radiol; 2023 Sep; 52(6):20230119. PubMed ID: 37395742
[TBL] [Abstract][Full Text] [Related]
23. Does inflammatory dental disease affect the development of medication-related osteonecrosis of the jaw in patients using high-dose bone-modifying agents?
Ueda N; Nakashima C; Aoki K; Shimotsuji H; Nakaue K; Yoshioka H; Kurokawa S; Imai Y; Kirita T
Clin Oral Investig; 2021 May; 25(5):3087-3093. PubMed ID: 33057886
[TBL] [Abstract][Full Text] [Related]
24. Texture analysis using short-tau inversion recovery magnetic resonance images to differentiate squamous cell carcinoma of the gingiva from medication-related osteonecrosis of the jaw.
Ito K; Hirahara N; Muraoka H; Sawada E; Tokunaga S; Kaneda T
Oral Radiol; 2024 Apr; 40(2):219-225. PubMed ID: 38060046
[TBL] [Abstract][Full Text] [Related]
25. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
[TBL] [Abstract][Full Text] [Related]
26. Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.
Otsuru M; Hayashida S; Morishita K; Murata M; Soutome S; Sasaki M; Takagi Y; Sumi M; Umeda M
Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742679
[TBL] [Abstract][Full Text] [Related]
27. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
[TBL] [Abstract][Full Text] [Related]
28. The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma.
Lu SY; Ma MC; Wang MC; Hsue SS
J Formos Med Assoc; 2021 Nov; 120(11):1967-1976. PubMed ID: 33551311
[TBL] [Abstract][Full Text] [Related]
29. Computed tomographic assessment of early changes of the mandible in bisphosphonate-treated patients.
Taniguchi T; Ariji Y; Nozawa M; Naitoh M; Kuroiwa Y; Kurita K; Ariji E
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Sep; 122(3):362-72. PubMed ID: 27544397
[TBL] [Abstract][Full Text] [Related]
30. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
[TBL] [Abstract][Full Text] [Related]
31. Further development of the MRONJ minipig large animal model.
Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
[TBL] [Abstract][Full Text] [Related]
32. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
[TBL] [Abstract][Full Text] [Related]
33. Medication-Related Osteonecrosis of the Jaw-Comparison of Bone Imaging Using Ultrashort Echo-Time Magnetic Resonance Imaging and Cone-Beam Computed Tomography.
Huber FA; Schumann P; von Spiczak J; Wurnig MC; Klarhöfer M; Finkenstaedt T; Bedogni A; Guggenberger R
Invest Radiol; 2020 Mar; 55(3):160-167. PubMed ID: 31688157
[TBL] [Abstract][Full Text] [Related]
34. Multiple myeloma masquerading as mandibular medication-related osteonecrosis of the jaw: a case report.
Danskin Y; Alhajji D; Singh A; Rota A; Huryn JM; Estilo CL
Aust Dent J; 2022 Mar; 67(1):94-99. PubMed ID: 34706097
[TBL] [Abstract][Full Text] [Related]
35. [Research progress in the treatment and prevention of medication-related osteonecrosis of the jaw].
Xu LC; Li YF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Jul; 55(7):509-514. PubMed ID: 32634892
[TBL] [Abstract][Full Text] [Related]
36. Meaning and Limitation of Cortical Bone Width Measurement with DentaScan in Medication-Related Osteonecrosis of the Jaws.
Iwata E; Akashi M; Kishimoto M; Kusumoto J; Hasegawa T; Furudoi S; Komori T
Kobe J Med Sci; 2017 Feb; 62(5):E114-E119. PubMed ID: 28289268
[TBL] [Abstract][Full Text] [Related]
37. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
[TBL] [Abstract][Full Text] [Related]
38. Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Soutome S; Hayashida S; Funahara M; Sakamoto Y; Kojima Y; Yanamoto S; Umeda M
PLoS One; 2018; 13(7):e0201343. PubMed ID: 30048523
[TBL] [Abstract][Full Text] [Related]
39. Does Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Facilitate Treatment of Medication-Related Osteonecrosis of the Jaw?
Fleisher KE; Pham S; Raad RA; Friedman KP; Ghesani M; Chan KC; Amintavakoli N; Janal M; Levine JP; Glickman RS
J Oral Maxillofac Surg; 2016 May; 74(5):945-58. PubMed ID: 26657395
[TBL] [Abstract][Full Text] [Related]
40. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
Diniz-Freitas M; Fernández-Feijoo J; Diz Dios P; Pousa X; Limeres J
J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
